<DOC>
	<DOCNO>NCT00162045</DOCNO>
	<brief_summary>The purpose Phase I-II multicenter clinical trial establish dosimetry safety profile CARDIOLITE® ( Technetium Tc99m Sestamibi ) pediatric subject .</brief_summary>
	<brief_title>A Trial Determine Radiation Exposure Organs Assess Safety CARDIOLITE® Pediatric Subjects</brief_title>
	<detailed_description />
	<mesh_term>Mucocutaneous Lymph Node Syndrome</mesh_term>
	<mesh_term>Technetium Tc 99m Sestamibi</mesh_term>
	<criteria>Have schedule undergo clinically indicate rest stress CARDIOLITE® MPI scan . Be able comply image requirement permit completion rest stress CARDIOLITE® wholebody scan SPECT imaging procedure without use sedation . Have terminal illness expect survival ≤6 month Have know clinically significant laboratory abnormality ( creatine , liver enzymes , platelet count ) .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>